Steiner CA, Cartwright IM, Taylor CT, Colgan SP. Hypoxia-inducible factor as a bridge between healthy barrier function, wound healing, and fibrosis. Am J Physiol Cell Physiol. 2022 Sep 1;323(3):C866-C878. PubMed PMID: 35912990
Cartwright IM, Dowdell AS, Hanson C, Kostelecky RE, Welch N, Steiner CA, Colgan SP. Contact-dependent, polarized acidification response during neutrophil-epithelial interactions. J Leukoc Biol. 2022 Dec;112(6):1543-1553. PubMed PMID: 35674095
Sheehan JL, Jacob J, Berinstein EM, Greene-Higgs L, Steiner CA, Berry SK, Shannon C, Cohen-Mekelburg SA, Higgins PDR, Berinstein JA. The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Inflamm Bowel Dis. 2022 Dec 1;28(12):1904-1914. PubMed PMID: 35230420
Steiner CA, Rieder F. No Longer Stretching Credibility: Mechanical Force Meets Inflammation in Experimental Intestinal Stenosis. Dig Dis Sci. 2022 May;67(5):1702-1703. PubMed PMID: 34350517
Johnson LA, Rodansky ES, Tran A, Collins SG, Eaton KA, Malamet B, Steiner CA, Huang S, Spence JR, Higgins PDR. Effect of ABT-263 on Intestinal Fibrosis in Human Myofibroblasts, Human Intestinal Organoids, and the Mouse Salmonella typhimurium Model. Inflamm Bowel Dis. 2022 Feb 1;28(2):161-175. PubMed PMID: 34302470
Steiner CA, Berinstein JA, Louissaint J, Higgins PDR, Spence JR, Shannon C, Lu C, Stidham RW, Fletcher JG, Bruining DH, Feagan BG, Jairath V, Baker ME, Bettenworth D, Rieder F. Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn's Disease: A Systematic Review. Clin Gastroenterol Hepatol. 2022 Apr;20(4):817-846.e10. PubMed PMID: 34089850
Steiner C. A commentary on: Complete endoscopic healing is associated with a lower relapse risk after anti-TNF withdrawal in inflammatory bowel disease. PracticeUpdate website. Available at: https://www.practiceupdate.com/content/complete-endoscopic-healing-lowers-relapse-risk-after-anti-tnf-therapy-withdrawal-in-ibd/141630/65/9/1. Accessed October 10, 2022
Steiner C. A commentary on: Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis. PracticeUpdate website. Available at: https://www.practiceupdate.com/content/ozanimod-as-therapy-for-ulcerative-colitis/132003/65/9/1. Accessed March 04, 2022
Steiner CA, Rodansky ES, Johnson LA, Berinstein JA, Cushing KC, Huang S, Spence JR, Higgins PDR. AXL Is a Potential Target for the Treatment of Intestinal Fibrosis. Inflamm Bowel Dis. 2021 Feb 16;27(3):303-316. PubMed PMID: 32676663
Berinstein JA, Cohen-Mekelburg SA, Steiner CA, McLeod M, Noureldin M, Allen JI, Kullgren JT, Waljee AK, Higgins PDR. Variations in Health Care Utilization Patterns Among Inflammatory Bowel Disease Patients at Risk for High Medical Service Utilization Enrolled in High Deductible Health Plans. Inflamm Bowel Dis. 2021 May 17;27(6):771-778. PubMed PMID: 32676638
Berinstein JA, Steiner CA, Roth KJ, Briggs E, Rao K, Higgins PDR. Association of Household Pets, Common Dietary Factors, and Lifestyle Factors with Clostridium difficile Infection. Dig Dis Sci. 2021 Jan;66(1):206-212. PubMed PMID: 32036514
Berinstein JA, Sheehan JL, Dias M, Berinstein EM, Steiner CA, Johnson LA, Regal RE, Allen JI, Cushing KC, Stidham RW, Bishu S, Kinnucan JAR, Cohen-Mekelburg SA, Waljee AK, Higgins PDR. Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study. Clin Gastroenterol Hepatol. 2021 May 25:S1542-3565(21)00576-0. doi: 10.1016/j.cgh.2021.05.038. Epub ahead of print. PMID: 34048936.
Steiner CA, Berinstein JA, Louissaint J, Higgins PDR, Spence JR, Shannon C, Lu C, Stidham RW, Fletcher JG, Bruining DH, Feagan BG, Jairath V, Baker ME, Bettenworth D, Rieder F; Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium. Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn's Disease: A Systematic Review. Clin Gastroenterol Hepatol. 2021 Jun 2:S1542-3565(21)00593-0. doi: 10.1016/j.cgh.2021.05.054. Epub ahead of print. PMID: 34089850.
Steiner CA, Berinstein JA, Louissaint J, Higgins PDR, Spence JR, Shannon C, Lu C, Stidham RW, Fletcher JG, Bruining DH, Feagan BG, Jairath V, Baker ME, Bettenworth D, Rieder F. Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn's Disease: A Systematic Review. Clin Gastroenterol Hepatol. 2021 Jun 2. [Epub ahead of print] PubMed PMID: 34089850
Berinstein JA, Sheehan JL, Dias M, Berinstein EM, Steiner CA, Johnson LA, Regal RE, Allen JI, Cushing KC, Stidham RW, Bishu S, Kinnucan JAR, Cohen-Mekelburg SA, Waljee AK, Higgins PDR. Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study. Clin Gastroenterol Hepatol. 2021 Oct;19(10):2112-2120.e1. PubMed PMID: 34048936
Johnson LA, Rodansky ES, Tran A, Collins SG, Eaton KA, Malamet B, Steiner CA, Huang S, Spence JR, Higgins PDR. Effect of ABT-263 on Intestinal Fibrosis in Human Myofibroblasts, Human Intestinal Organoids, and the Mouse Salmonella typhimurium Model. Inflamm Bowel Dis. 2021 Jul 24. [Epub ahead of print] PubMed PMID: 34302470
Steiner CA, Rodansky ES, Johnson LA, Berinstein JA, Cushing KC, Huang S, Spence JR, Higgins PDR. AXL Is a Potential Target for the Treatment of Intestinal Fibrosis. Inflamm Bowel Dis. 2021 Feb 16;27(3):303-316. PubMed PMID: 32676663
Berinstein JA, Cohen-Mekelburg SA, Steiner CA, McLeod M, Noureldin M, Allen JI, Kullgren JT, Waljee AK, Higgins PDR. Variations in Health Care Utilization Patterns Among Inflammatory Bowel Disease Patients at Risk for High Medical Service Utilization Enrolled in High Deductible Health Plans. Inflamm Bowel Dis. 2021 May 17;27(6):771-778. PubMed PMID: 32676638
Berinstein JA, Steiner CA, Roth KJ, Briggs E, Rao K, Higgins PDR. Association of Household Pets, Common Dietary Factors, and Lifestyle Factors with Clostridium difficile Infection. Dig Dis Sci. 2021 Jan;66(1):206-212. PubMed PMID: 32036514
Chen VL, Hawa F, Berinstein JA, Reddy CA, Kassab I, Platt KD, Hsu CY, Steiner CA, Louissaint J, Gunaratnam NT, Sharma P. Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19. Dig Dis Sci. 2021 Sep;66(9):3192-3198. PubMed PMID: 32980956
Steiner CA, Rieder, F. No Longer Stretching Credibility: Mechanical Force Meets Inflammation in Experimental Intestinal Stenosis. Digestive Diseases and Sciences. (2021). https://doi.org/10.1007/s10620-021-07170-4
Steiner CA, Bishu S. Concise Commentary: Armchair Science Redux-How Advanced In Silico Analysis Revealed Novel Insights into the Pathogenesis of Acute Pancreatitis. Dig Dis Sci. 2020 Jun;65(6):1733-1734. PubMed PMID: 31993895
Chen VL, Hawa F, Berinstein JA, Reddy CA, Kassab I, Platt KD, Hsu CY, Steiner CA, Louissaint J, Gunaratnam NT, Sharma P. Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19. Dig Dis Sci. 2020 Sep 27:1–7. doi: 10.1007/s10620-020-06618-3. Epub ahead of print. PMID: 32980956; PMCID: PMC7520076.
Xu D, Chen VL, Steiner CA, Berinstein JA, Eswaran S, Waljee AK, Higgins PDR, Owyang C. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2019 Jul;114(7):1043-1050. PubMed PMID: 30908299
Berinstein JA, Steiner CA, Regal RE, Allen JI, Kinnucan JAR, Stidham RW, Waljee AK, Bishu S, Aldrich LB, Higgins PDR. Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis. Clin Gastroenterol Hepatol. 2019 Apr;17(5):988-990.e1. PubMed PMID: 30458248
Jeffrey A Berinstein, MD, MSc, Calen A Steiner, MD, MS, Athos Bousvaros, MD, MPH, Felix P Tiongco, MD, Eugene Greenberg, MD, Robert Hardi, MD, Anthony J Lembo, MD, Keith Friedenberg, MD, Shahriar Sedghi, MD, Alison Fint, BS, David A Florez, MD, Ashutosh Kumar, MS, Razvan Arsenescu, MD, K T Park, MD, MS, Peter Kupchak, PhD, Alanna Grob, BS, MT, James Leavitt, MD, Peter D R Higgins, MD, PhD, MSc, The Clinical Accuracy of the BÜHLMANN fCAL ELISA in the Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome: A Multicenter Prospective Case–Control Study, Crohn's & Colitis 360, Volume 1, Issue 3, October 2019, otz037, https://doi.org/10.1093/crocol/otz037
Berinstein JA, Steiner CA, Higgins PDR. The IBD Therapeutic Pipeline is Primed to Produce. Practical Gastro, 2019 April; 43(4):24-26,30-32,38-40,42,44-45,52-54,56-60,52
Steiner C.A., Higgins P.D.R. (2018) Anti-Fibrotic Therapies from Other Organs: What the Gut Can Learn from the Liver, Skin, Lung and Heart. In: Rieder F. (eds) Fibrostenotic Inflammatory Bowel Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-90578-5_23
Steiner C.A., Whitfield E.P., Adler J., Higgins P.D.R. (2017) Anti-TNF Biologic Therapies Other than Infliximab. In: Mamula P., Grossman A., Baldassano R., Kelsen J., Markowitz J. (eds) Pediatric Inflammatory Bowel Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-49215-5_33
Serrone JC, Tackla RD, Gozal YM, Hanseman DJ, Gogela SL, Vuong SM, Kosty JA, Steiner CA, Krueger BM, Grossman AW, Ringer AJ. Aneurysm growth and de novo aneurysms during aneurysm surveillance. J Neurosurg. 2016 Dec;125(6):1374-1382. PubMed PMID: 26967775
Apostolova LG, Thompson PM, Rogers SA, Dinov ID, Zoumalan C, Steiner CA, Siu E, Green AE, Small GW, Toga AW, Cummings JL, Phelps ME, Silverman DH. Surface feature-guided mapping of cerebral metabolic changes in cognitively normal and mildly impaired elderly. Mol Imaging Biol. 2010 Apr;12(2):218-24. PubMed PMID: 19636640
Apostolova LG, Steiner CA, Akopyan GG, Dutton RA, Hayashi KM, Toga AW, Cummings JL, Thompson PM. Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease. Arch Neurol. 2007 Oct;64(10):1489-95. PubMed PMID: 17923632
Apostolova LG, Akopyan GG, Partiali N, Steiner CA, Dutton RA, Hayashi KM, Dinov ID, Toga AW, Cummings JL, Thompson PM. Structural correlates of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord. 2007;24(2):91-7. PubMed PMID: 17570907
Clinical Interests
My many clinical interests include the medical and endoscopic management of patients with Inflammatory Bowel Disease (IBD) including Crohn's Disease and Ulcerative Colitis.
Care Philosophy
I strive to provide the best care for my patients. I believe in a multidisciplinary and comprehensive approach to care for the person as a whole and delivering cutting edge, evidence-based care for our patients.
General Information
Medical Schools:
MD, University of Cincinnati College of Medicine
(2015)
Graduate Schools:
MS, University of Cincinnati
(2011)
Undergraduate Schools:
BS, University of California–Los Angeles (CA)
(2007)
Residency Programs:
University of Michigan Program, Internal Medicine (2018)
Fellowships:
University of Michigan Program, Gastroenterology
(2021)